CLINICAL_TRIALS
trial_result
· 2013-03-20
Clinical Trial Update: A Study of NK012 in Patients With Relapsed Small Cell Lung Cancer [Phase 2]
Summary
Phase 2 study of NK012 in patients with relapsed small cell lung cancer has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Nippon Kayaku Co., Ltd. | Conditions: Small Cell Lung Cancer | Phase 2 | Status: COMPLETED